News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A Series A financing round, led by Deerfield Management, is aimed at accelerating a new cell therapy modality for the treatment of neurological disorders, including Parkinson’s Disease.
A US federal judge ruling that a Californian clinic’s stromal vascular stem cell treatments do not fall under the FDA's regulatory jurisdiction is of significant concern, says the ISCT.
US president Joe Biden sets out a ‘whole-of-government approach to advance biotechnology and biomanufacturing’ in a new initiative announced today.
Experts from the health information specialist explain how the use of RWD and RWE has helped speed up and improve the development of therapies and vaccines.